The State of the Art of Molecular Fecal Investigations for <i>Helicobacter pylori</i> (<i>H. pylori</i>) Antibiotic Resistances

A new paradigm shift for the treatment of <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection would be timely due to a progressive increase in antibiotic resistance. Such a shift in the perspective of the <i>H. pylori</i> approach should include the preliminar...

Full description

Bibliographic Details
Main Authors: Francesca Celiberto, Giuseppe Losurdo, Maria Pricci, Bruna Girardi, Angela Marotti, Alfredo Di Leo, Enzo Ierardi
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/5/4361
_version_ 1797615260965797888
author Francesca Celiberto
Giuseppe Losurdo
Maria Pricci
Bruna Girardi
Angela Marotti
Alfredo Di Leo
Enzo Ierardi
author_facet Francesca Celiberto
Giuseppe Losurdo
Maria Pricci
Bruna Girardi
Angela Marotti
Alfredo Di Leo
Enzo Ierardi
author_sort Francesca Celiberto
collection DOAJ
description A new paradigm shift for the treatment of <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection would be timely due to a progressive increase in antibiotic resistance. Such a shift in the perspective of the <i>H. pylori</i> approach should include the preliminary assessment of antibiotic resistance. However, the availability of sensitivity tests is not widespread and the guidelines have always indicated empirical treatments without taking into account the need to make sensitivity tests accessible, i.e., the necessary starting point for improving results in different geographical areas. Currently, the traditional tools for this purpose (culture) are based on performing an invasive investigation (endoscopy) and often involve technical difficulties; thus, they were only confined to the settings where multiple attempts at eradication have failed. In contrast, genotypic resistance testing of fecal samples using molecular biology methods is much less invasive and more acceptable to patients. The purpose of this review is to update the state of the art of molecular fecal susceptibility testing for the management of this infection and to extensively discuss the potential benefits of their large-scale deployment, i.e., novel pharmacological opportunities.
first_indexed 2024-03-11T07:23:46Z
format Article
id doaj.art-a2b7458b6e7a431090c88202a955a404
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T07:23:46Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a2b7458b6e7a431090c88202a955a4042023-11-17T07:47:24ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-02-01245436110.3390/ijms24054361The State of the Art of Molecular Fecal Investigations for <i>Helicobacter pylori</i> (<i>H. pylori</i>) Antibiotic ResistancesFrancesca Celiberto0Giuseppe Losurdo1Maria Pricci2Bruna Girardi3Angela Marotti4Alfredo Di Leo5Enzo Ierardi6Section of Gastroenterology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, 70124 Bari, ItalySection of Gastroenterology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, 70124 Bari, ItalyTHD SpA, 42015 Correggio, ItalyTHD SpA, 42015 Correggio, ItalySection of Gastroenterology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, 70124 Bari, ItalySection of Gastroenterology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, 70124 Bari, ItalySection of Gastroenterology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, 70124 Bari, ItalyA new paradigm shift for the treatment of <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection would be timely due to a progressive increase in antibiotic resistance. Such a shift in the perspective of the <i>H. pylori</i> approach should include the preliminary assessment of antibiotic resistance. However, the availability of sensitivity tests is not widespread and the guidelines have always indicated empirical treatments without taking into account the need to make sensitivity tests accessible, i.e., the necessary starting point for improving results in different geographical areas. Currently, the traditional tools for this purpose (culture) are based on performing an invasive investigation (endoscopy) and often involve technical difficulties; thus, they were only confined to the settings where multiple attempts at eradication have failed. In contrast, genotypic resistance testing of fecal samples using molecular biology methods is much less invasive and more acceptable to patients. The purpose of this review is to update the state of the art of molecular fecal susceptibility testing for the management of this infection and to extensively discuss the potential benefits of their large-scale deployment, i.e., novel pharmacological opportunities.https://www.mdpi.com/1422-0067/24/5/4361<i>Helicobacter pylori</i>stoolsantibiotic resistancetherapyeradicationgenotypic resistance
spellingShingle Francesca Celiberto
Giuseppe Losurdo
Maria Pricci
Bruna Girardi
Angela Marotti
Alfredo Di Leo
Enzo Ierardi
The State of the Art of Molecular Fecal Investigations for <i>Helicobacter pylori</i> (<i>H. pylori</i>) Antibiotic Resistances
International Journal of Molecular Sciences
<i>Helicobacter pylori</i>
stools
antibiotic resistance
therapy
eradication
genotypic resistance
title The State of the Art of Molecular Fecal Investigations for <i>Helicobacter pylori</i> (<i>H. pylori</i>) Antibiotic Resistances
title_full The State of the Art of Molecular Fecal Investigations for <i>Helicobacter pylori</i> (<i>H. pylori</i>) Antibiotic Resistances
title_fullStr The State of the Art of Molecular Fecal Investigations for <i>Helicobacter pylori</i> (<i>H. pylori</i>) Antibiotic Resistances
title_full_unstemmed The State of the Art of Molecular Fecal Investigations for <i>Helicobacter pylori</i> (<i>H. pylori</i>) Antibiotic Resistances
title_short The State of the Art of Molecular Fecal Investigations for <i>Helicobacter pylori</i> (<i>H. pylori</i>) Antibiotic Resistances
title_sort state of the art of molecular fecal investigations for i helicobacter pylori i i h pylori i antibiotic resistances
topic <i>Helicobacter pylori</i>
stools
antibiotic resistance
therapy
eradication
genotypic resistance
url https://www.mdpi.com/1422-0067/24/5/4361
work_keys_str_mv AT francescaceliberto thestateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT giuseppelosurdo thestateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT mariapricci thestateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT brunagirardi thestateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT angelamarotti thestateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT alfredodileo thestateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT enzoierardi thestateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT francescaceliberto stateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT giuseppelosurdo stateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT mariapricci stateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT brunagirardi stateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT angelamarotti stateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT alfredodileo stateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances
AT enzoierardi stateoftheartofmolecularfecalinvestigationsforihelicobacterpyloriiihpyloriiantibioticresistances